|
Sánchez-del-Campo L, Sáez-Ayala M, Chazarra S, Cabezas-Herrera J, Rodríguez-López JN. Binding of natural and synthetic polyphenols to human dihydrofolate reductase. Int J Mol Sci. 2009 Dec 18;10(12):5398-410. doi: 10.3390/ijms10125398. PubMed PMID: 20054477; PubMed Central PMCID: PMC2802001.
AÑO: 2009; IF: 1.387
|
20054477
|
Sánchez-del-Campo L, Otón F, Tárraga A, Cabezas-Herrera J, Chazarra S, Rodríguez-López JN. Synthesis and biological activity of a 3,4,5-trimethoxybenzoyl ester analogue of epicatechin-3-gallate. J Med Chem. 2008 Apr 10;51(7):2018-26. doi: 10.1021/jm701346h. Epub 2008 Mar 7. PubMed PMID: 18324763.
AÑO: 2008; IF: 4.898
|
|
Navarro-Perán E, Cabezas-Herrera J, Sánchez-Del-Campo L, García-Cánovas F, Rodríguez-López JN. The anti-inflammatory and anti-cancer properties of epigallocatechin-3-gallate are mediated by folate cycle disruption, adenosine release and NF-kappaB suppression. Inflamm Res. 2008 Oct;57(10):472-8. doi: 10.1007/s00011-008-8013-x. PubMed PMID: 18830563.
AÑO: 2008; IF: 1.457
|
|
Sánchez-del-Campo L, Rodríguez-López JN. Targeting the methionine cycle for melanoma therapy with 3-O-(3,4,5-trimethoxybenzoyl)-(-)-epicatechin. Int J Cancer. 2008 Nov 15;123(10):2446-55. doi: 10.1002/ijc.23813. PubMed PMID: 18729182.
AÑO: 2008; IF: 4.734
|
|
Sánchez del Campo LF, Nieto-Cerón S, Morote-García JC, Muñoz-Delgado E, Vidal CJ, Campoy FJ. Butyrylcholinesterase activity and molecular components in thymus of healthy and merosin-deficient Lama2dy mice. Neurochem Int. 2007 Feb;50(3):531-9. Epub 2006 Dec 18. PubMed PMID: 17178175.
AÑO: 2007; IF: 2.975
|